Molekularbiologie und „targeted therapy“ beim Pleuramesotheliom

Sheng Xiao, J. M. Corson, D. J. Sugarbaker, J. A. Fletcher, J. Vijg, Daizong Li, CODELETION OF P15 AND P16 IN PRIMARY MALIGNANT MESOTHELIOMA Oncogene. ,vol. 11, pp. 511- 515 ,(1995)

TIMOTHY I. CHRISTMAS, LINDA S. MANNING, MICHAEL J. GARLEPP, ARTHUR W. MUSK, BRUCE W.S. ROBINSON, Effect of Interferon-α2a Malignant Mesothelioma Journal of interferon research. ,vol. 13, pp. 9- 12 ,(1993) , 10.1089/JIR.1993.13.9

Bruce W. S. Robinson, David R. Fitzpatrick, Bernadette Scott, Amanda L. Marzo, Antisense Oligonucleotides Specific for Transforming Growth Factor β2 Inhibit the Growth of Malignant Mesothelioma Both in Vitro and in Vivo Cancer Research. ,vol. 57, pp. 3200- 3207 ,(1997)

Kenneth J. O’Byrne, John G. Edwards, Rosemary A. Walker, Keith R. Abrams, Stephen P. Faux, Simon M. Plummer, David A. Waller, Cyclooxygenase-2 Expression Is a Novel Prognostic Factor in Malignant Mesothelioma Clinical Cancer Research. ,vol. 8, pp. 1857- 1862 ,(2002)

Barbara Imberti, Patrizia Borsotti, Raffaella Giavazzi, Giulia Taraboletti, Maura Poli, Michele Martinelli, Gianluca Micheletti, Vascular-targeting activity of ZD6126, a novel tubulin-binding agent. Cancer Research. ,vol. 63, pp. 1534- 1537 ,(2003)

Michele L Taffaro, Bruce E Johnson, Ravi Salgia, Pasi A Jänne, Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma. Cancer Research. ,vol. 62, pp. 5242- 5247 ,(2002)

Angus G. Dalgleish, Ken J. O'Byrne, Chronic immune activation and inflammation in the pathogenesis of aids and cancer Advances in Cancer Research. ,vol. 84, pp. 231- 276 ,(2002) , 10.1016/S0065-230X(02)84008-8

J. Blake Bartlett, Keith Dredge, Angus G. Dalgleish, The evolution of thalidomide and its IMiD derivatives as anticancer agents Nature Reviews Cancer. ,vol. 4, pp. 314- 322 ,(2004) , 10.1038/NRC1323

Daniel George, Targeting Pdgf Receptors in Cancer ­ Rationales and Proof of Concept Clinical Trials Advances in Experimental Medicine and Biology. ,vol. 532, pp. 141- 151 ,(2003) , 10.1007/978-1-4615-0081-0_12

Linda J. Metheny-Barlow, Barbara Flynn, Hilde E. van Gijssel, Aizen Marrogi, Brenda I. Gerwin, Paradoxical effects of platelet-derived growth factor-A overexpression in malignant mesothelioma. Antiproliferative effects in vitro and tumorigenic stimulation in vivo. American Journal of Respiratory Cell and Molecular Biology. ,vol. 24, pp. 694- 702 ,(2001) , 10.1165/AJRCMB.24.6.4334